Loading clinical trials...
Loading clinical trials...
The goal of this open label 16 week trial is to evaluate Lp(a) levels for patients with elevated Lp(a) being treated with obicetrapib and obiceptrapib/evolocumab Patients will: Have baseline Lp(a) t...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
NewAmsterdam Pharma
NCT04634591 · Obesity, Diabetes Mellitus, and more
NCT06526273 · Type 2 Diabetes, Hypertension, and more
NCT07308314 · Chronic Disease, Chronic Disease Management, and more
NCT06380322 · Hypertension, Type 2 Diabetes, and more
NCT07083206 · Hypercholesterolemia, Dyslipidemias
UPenn
Philadelphia, Pennsylvania
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions